Thermal and Cardiovascular Responses during Exertional Heat Stress after Diphenhydramine Use: A Randomized Crossover Trial.


Journal

Medicine and science in sports and exercise
ISSN: 1530-0315
Titre abrégé: Med Sci Sports Exerc
Pays: United States
ID NLM: 8005433

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Despite sparse systematic evidence, current exercise heat safety recommendations suggest that antihistamines blunt sweating and increase the risk for heat-related injury during exertional heat stress. The primary purpose of the present study was to examine whether diphenhydramine hydrochloride (DPH), a first-generation antihistamine, effects the sweating, core temperature, and heart rate response during exertional heat stress using a double-blind randomized crossover design. On two occasions separated by >48 h, 20 healthy adults (10 females, 23 ± 3 y, BSA: 1.9 ± 0.2 m2, BMI: 23.7 ± 2.2 kg·m-2) orally consumed either 50 mg of DPH or placebo (PLA), and then rested for 2 h in a climate-controlled room maintained at 30 °C and 35%RH (Heat Index of ~29 °C), followed by a 60-minute fixed-heat production treadmill walk (6.3 ± 1.0 W·kg-1). Whole-body sweat loss (WBSL), local sweat rate (LSR), rectal temperature (Trec), and heart rate (HR) were measured. WBSL was not different between conditions (PLA: 406 ± 78 g; DPH: 396 ± 75 g, P = 0.26, treatment effect: -10 g 95%CI [-28, 8]). No differences were observed for the onset for sweating (PLA: 13.5 ± 2.4 min; DPH: 13.3 ± 2.7 mins, P = 0.79), and steady-state LSR (PLA: 0.83 ± 0.26 mg·cm-2·min-1; DPH: 0.82 ± 0.27 mg·cm-2·min-1, P = 0.99). No difference in baseline Trec was observed (PLA: 37.09 ± 0.35 °C, DPH: 37.13 ± 0.33 °C, P = 0.68), and the 60-min ΔTrec was not different (P = 0.99) between PLA (0.83 ± 0.29 °C) and DPH (0.81 ± 0.30 °C). HR was similar at baseline (PLA: 86 ± 13 BPM, DPH: 84 ± 11 BPM, P = 0.30) and end-exercise (PLA: 134 ± 28 BPM, DPH: 132 ± 26BPM, P = 0.90). 50 mg of DPH does not modify the sweating, core temperature, and heart rate response during exertional heat stress in young healthy adults.

Identifiants

pubmed: 39140777
doi: 10.1249/MSS.0000000000003527
pii: 00005768-990000000-00584
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American College of Sports Medicine.

Déclaration de conflit d'intérêts

Conflict of Interest and Funding Source: This research was supported by Dr. Ravanelli’s Research Seed Grant from the Centre for Research in Occupational Safety & Health, and by Dr. Ravanelli’s Natural Sciences and Engineering Research Council of Canada Discovery Grant (PIN#2022-05096). Dr. Nicholas Ravanelli is an executive faculty member at the Centre for Research in Occupational Safety & Health. All other authors have no conflicts of interest that are directly relevant to the content of this article.

Auteurs

Emily Mihalcin (E)

School of Kinesiology, Lakehead University, Thunder Bay, Ontario, CANADA.

KarLee Lefebvre (K)

School of Kinesiology, Lakehead University, Thunder Bay, Ontario, CANADA.

Mario Nucci (M)

Northern Ontario School of Medicine University, Thunder Bay, Ontario, CANADA.

Classifications MeSH